Emerging Company Showcase

Returning for its fifth year as a part of the conference program, The Neurotech Investing and Partnering Conference’s Emerging Company Showcase will once again feature young neurotechnology startup companies on the main stage to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.

To be eligible to participate, companies must be:

  • Addressing an unmet medical need
  • Founded no earlier than 2014
  • Actively seeking funding (startups that have raised more than $2 million in private capital or that had more than $1M in revenue in 2019 are not eligible for this showcase)

For priority consideration, please submit your information via the form below no later than Friday, March 27, 2020 for consideration. Selected companies will be notified via email and receive a discounted registration rate.

Please note that all companies must have a valid email address and phone number to be eligible for participation in the Emerging Company Showcase. A recent news article or webpage from an investor or parent company may be submitted in lieu of a company website.


Area of Neurotechnology
Prefix